Correlation Between Evoke Pharma and Avadel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evoke Pharma and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Evoke Pharma and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Avadel Pharmaceuticals.

Diversification Opportunities for Evoke Pharma and Avadel Pharmaceuticals

0.55

Correlation Coefficient

Evoke Pharma  Avadel Pharmaceuticals

Very weak diversification

The 3 months correlation between Evoke and Avadel is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Avadel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Evoke Pharma and Avadel Pharmaceuticals

Given the investment horizon of 90 days Evoke Pharma is expected to generate 1.33 times more return on investment than Avadel Pharmaceuticals. However, Evoke Pharma is 1.33 times more volatile than Avadel Pharmaceuticals PLC. It trades about 0.02 of its potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about -0.07 per unit of risk. If you would invest  419.00  in Evoke Pharma on September 12, 2024 and sell it today you would lose (9.00) from holding Evoke Pharma or give up 2.15% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Evoke Pharma  vs.  Avadel Pharmaceuticals PLC

Evoke Pharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Evoke Pharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Evoke Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Avadel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Evoke Pharma and Avadel Pharmaceuticals

The main advantage of trading using opposite Evoke Pharma and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.

The idea behind Evoke Pharma and Avadel Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.